INTERNATIONAL PATENT: THE CHINESE UNIVERSITY OF HONG KONG FILES APPLICATION FOR "BILOBALIDE DERIVATIVE COMPOUNDS FOR TREATING NEUROLOGICAL DISEASES AND CANCERS"

GENEVA, Feb. 15 -- THE CHINESE UNIVERSITY OF HONG KONG (Shatin, New TerritoriesHong Kong) filed a patent application (PCT/CN2024/109675) for "BILOBALIDE DERIVATIVE COMPOUNDS FOR TREATING NEUROLOGICAL DISEASES AND CANCERS" on Aug 03, 2024. With publication no. WO/2025/031304, the details related to the patent application was published on Feb 13, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): NG, Wai Lung (Room 801P, Lo Kwee-Seong Integrated Biomedical Sciences Bldg, Area 39, The Chinese University Of Hong Kong, Shatin, N.T.Hong Kong), SCHEEFF, Stephan Juergen Wolfgang (11/F, 83A, Prince Edwa...